The Peptide Research Wiki
for Science-Based Information
Evidence-based profiles for BPC-157, semaglutide, GHK-Cu, and 74 more research compounds — with PubMed citations, mechanism breakdowns, and a free reconstitution calculator.
All data is provided for laboratory research purposes only. Not for human or animal consumption. All referenced compounds are research reagents.
Browse Peptides by Research Area
Most-Researched Compounds
BPC-157
Tissue RepairBody Protective Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from gastric proteins that has demonstrated notable reparative and anti-inflammatory properties across diverse preclinica…
Semaglutide
MetabolicGlucagon-like peptide-1 (GLP-1) receptor agonists are widely used for the management of obesity; however, respiratory complications are rarely documented. A 40-year-old person without diabetes with ob…
CJC-1295
Growth Hormone SecretagogueThe pursuit of pharmacological enhancement in sport has evolved from the widespread use of anabolic-androgenic steroids (AAS) to novel agents such as peptides and peptide analogues. Marketed as more s…
Epitalon
Anti-AgingEpitalon, a naturally occurring tetrapeptide, is known for its anti-aging effects on mammalian cells. This happens through the induction of telomerase enzyme activity, resulting in the extension of te…
Semax
NeurologicalAlzheimer's disease, first described over a century ago, is currently among the most common neurodegenerative diseases whose significance is increasingly growing with the aging of populations. Through…
Tirzepatide
MetabolicINTRODUCTION: Tirzepatide has been associated with significant reductions in body weight in randomized clinical trials. However, real-world evidence evaluating the multisystemic effects of tirzepatide…
Browse by What You're Studying
Find the right compounds faster. Each goal links directly to the relevant category in the compound library.
Compound Comparisons
Structured mechanism comparisons for the most-searched compound pairs — receptor pharmacology, pharmacokinetics, and published study data.
Latest from the research blog
Plain-English summaries of recent peptide research, with primary citations.
Ecnoglutide vs Semaglutide: GLP-1 Mono-Agonist Mechanism and Phase 3 Data Compared
Ecnoglutide's Phase 3 SLIMMER trial reported 13.2% weight loss at 40 weeks — see how its biased cAMP GLP-1 mechanism compares to semaglutide's approved profile.
Anamorelin vs MK-677: Comparing Oral Ghrelin-Receptor Agonists in Research
Anamorelin's Phase III ROMANA trials and MK-677's case-report data offer different evidence bases for ghrelin research; compare mechanisms and FDA status.
Pemvidutide vs Survodutide: GLP-1/Glucagon Dual Agonist Comparison for Metabolic Research
Pemvidutide and survodutide are both Phase 2/3 GLP-1/glucagon dual agonists: compare their 16.6% vs 15.6% weight-loss data, MASH trial results, and FDA status.
Icotrokinra vs Thymosin Alpha-1: Comparing Two Immunomodulatory Research Peptides
Icotrokinra, FDA-approved for psoriasis in 2026, blocks IL-23 receptors orally; Thymosin Alpha-1 rebalances T-cells in liver research. See how they compare.
Maridebart Cafraglutide vs Retatrutide: Two Approaches to Triple-Pathway Weight Loss Research
Maridebart cafraglutide antagonizes GIP; retatrutide agonizes it. Both hit ~20% Phase 2 weight loss — compare receptor mechanisms, dosing, and Phase 3 status.
NAD+ Research Compound: Mechanism, Mitochondrial Function, and Evidence Overview
NAD+ is a coenzyme, not a peptide: this overview covers its redox mechanism, AMPK-sirtuin signaling, MOTS-c crosstalk, and what preclinical evidence shows.
Volumetric Reconstitution Calculator
Enter your vial parameters — the syringe updates live. U-100 and tuberculin configurations.